Related Experiment Video
Updated: Mar 26, 2026

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
Published on: October 10, 2025
Dydrogesterone and pre-term birth.
Progestin supplementation, like dydrogesterone, shows promise in preventing and treating pre-term labor by modulating immune responses. This approach supports successful pregnancy by enhancing progesterone-induced blocking factor (PIBF) and beneficial cytokines.
Area of Science:
- Immunology
- Reproductive Medicine
- Obstetrics
Background:
- Successful pregnancy relies on maternal immune tolerance of the semi-allograft fetus.
- Progesterone-induced blocking factor (PIBF) mediates progesterone's immunological effects by promoting Th2 cytokine production.
- The role of progestogens in preventing or treating pre-term labor requires further clarification.
Purpose of the Study:
- To investigate the potential of progestin supplementation in preventing and treating pre-term labor.
- To assess the impact of dydrogesterone on immunological markers associated with pre-term birth.
Main Methods:
- Treatment of women at risk of pre-term delivery with dydrogesterone.
- Measurement of progesterone-induced blocking factor (PIBF) and cytokine concentrations (IL-10, IFNγ).
Main Results:
- Dydrogesterone treatment increased PIBF and IL-10 concentrations.
- Dydrogesterone treatment led to lower concentrations of IFNγ.
- These immunological changes suggest a potential benefit for pre-term labor management.
Conclusions:
- Progestin supplementation, specifically dydrogesterone, may be effective in preventing and treating pre-term labor.
- The observed modulation of PIBF and cytokine profiles supports progestins' role in maintaining pregnancy.
- Further randomized controlled studies are necessary to confirm these findings and establish clinical efficacy.
More Related Videos
09:57In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Related Concept Videos
Intrauterine Drug Delivery Systems
Teratogenicity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Birth Control Methods